NuVascular Technologies and Worcester Polytechnic Institute commercializing stem cell treatment to repair heart damage

NuVascular Technologies, Inc. has recently obtained exclusive licensing rights to commercialize a breakthrough medical device that will provide a minimally invasive treatment for heart disease, the No. 1 cause of death in the United States accounting for one in every four deaths. Source: Medical News Today Read More

Medical News Today